EliA RF IgM Well, REF 14-5600-01 Product Usage: Usage: EliA RF IgM is intended for the in vi...

FDA Device Recall #Z-1907-2019 — Class II — May 10, 2019

Recall Summary

Recall Number Z-1907-2019
Classification Class II — Moderate risk
Date Initiated May 10, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Phadia Ab
Location Uppsala, N/A
Product Type Devices
Quantity 30 kits

Product Description

EliA RF IgM Well, REF 14-5600-01 Product Usage: Usage: EliA RF IgM is intended for the in vitro quantitative measurement of IgM class rheumatoid factor antibodies in human serum and plasma (Li-heparin and EDTA) to aid in the diagnosis of rheumatoid arthritis in conjunction with other laboratory and clinical findings. EliA RF IgM uses the EliA IgM method on the instrument Phadia 100, Phadia 250, Phadia 2500 and Phadia 5000.

Reason for Recall

Potential for reporting low assay results

Distribution Pattern

US Nationwide n the states of NJ, NY, MI, WV, TX including PR

Lot / Code Information

UDI (01) 07333066010854 (17) 200630 (10) 0085 Lot Number - 0085

Other Recalls from Phadia Ab

Recall # Classification Product Date
Z-0783-2024 Class II EliA GBM Wells, Material Number 14551401, for P... May 24, 2023
Z-2397-2019 Class II Phadia" 1000 Model # 12-3800-01 Product Usa... Jul 9, 2019
Z-1276-2018 Class II Phadia Prime software, article number 12-4101-0... Nov 20, 2017
Z-0697-2016 Class II EliA SmDP Well, Article Number 14-5624-01 Pr... Dec 28, 2015

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.